文献速递糖尿病

美国学术医疗中心成年1型糖尿病患者糖尿病技术获取与使用的种族差异

Racial Disparities in Access and Use of Diabetes Technology Among Adult Patients With Type 1 Diabetes in a U.S. Academic Medical Center.
PubMed 文献 · Diabetes Care · 2023-01-01

这项回顾性门诊队列研究纳入2013年4月至2020年1月连续就诊的1258例成年1型糖尿病患者,比较黑人与非黑人患者在胰岛素泵和持续葡萄糖监测使用、讨论及处方上的差异。黑人患者基线及当前使用率均显著更低,调整社会健康决定因素和糖尿病结局后,CGM讨论和处方、胰岛素泵处方的 odds 仍显著更低。作者结论为存在显著种族差异,需进一步研究以识别原因并制定减少差异的策略。

要点

  • 黑人患者基线CGM使用7.9% vs 非黑人30.3%,胰岛素泵使用18.7% vs 49.6%。
  • 黑人患者当前CGM使用43.6% vs 非黑人72.1%,胰岛素泵使用30.7% vs 64.2%。
  • 调整后黑人患者CGM讨论aOR 0.51、CGM处方aOR 0.61、胰岛素泵处方aOR 0.40。

核心结论

  • 在成年1型糖尿病患者中观察到糖尿病技术的讨论、处方和使用存在显著种族差异。
  • 需要进一步研究以识别这些差异背后的原因,并制定和评估减少差异的策略。

研究设计与样本

  • 回顾性门诊队列研究,连续纳入2013年4月至2020年1月就诊的成年1型糖尿病患者。
  • 共纳入1258例成年1型糖尿病患者,种族分为非黑人(参照组)和黑人。
  • 主要结局为基线和当前技术使用、糖尿病技术讨论率(CGMdiscn、PUMPdiscn)和处方率(CGMrx、PUMPrx)。
  • 采用多变量逻辑回归分析技术讨论和处方与种族的关联,并调整社会健康决定因素和糖尿病结局。

主要发现

  • 黑人患者基线CGM使用7.9% vs 非黑人患者30.3%,基线胰岛素泵使用18.7% vs 49.6%。
  • 黑人患者当前CGM使用43.6% vs 非黑人患者72.1%,当前胰岛素泵使用30.7% vs 64.2%。
  • 黑人患者CGM讨论的调整后OR为0.51(95%CI 0.29, 0.90),CGM处方的调整后OR为0.61(95%CI 0.41, 0.93)。
  • 黑人患者胰岛素泵讨论的调整后OR为0.74(95%CI 0.44, 1.25),胰岛素泵处方的调整后OR为0.40(95%CI 0.22, 0.70)。
  • 社区环境、保险、婚姻和就业状况以及门诊就诊次数也与结局相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recent studies highlight racial disparities in insulin pump (PUMP) and continuous glucose monitor (CGM) use in children and adolescents with type 1 diabetes (T1D). This study explored racial disparities in diabetes technology among adult patients with T1D. RESEARCH DESIGN AND METHODS: This was a retrospective clinic-based cohort study of adult patients with T1D seen consecutively from April 2013 to January 2020. Race was categorized into non-Black (reference group) and Black. The primary outcomes were baseline and prevalent technology use, rates of diabetes technology discussions (CGMdiscn, PUMPdiscn), and prescribing (CGMrx, PUMPrx). Multivariable logistic regression analysis evaluated the association of technology discussions and prescribing with race, adjusting for social determinants of health and diabetes outcomes. RESULTS: Among 1,258 adults with T1D, baseline technology use was significantly lower for Black compared with non-Black patients (7.9% vs. 30.3% for CGM; 18.7% vs. 49.6% for PUMP), as was prevalent use (43.6% vs. 72.1% for CGM; 30.7% vs. 64.2% for PUMP). Black patients had adjusted odds ratios (aORs) of 0.51 (95% CI 0.29, 0.90) for CGMdiscn and 0.61 (95% CI 0.41, 0.93) for CGMrx. Black patients had aORs of 0.74 (95% CI 0.44, 1.25) for PUMPdiscn and 0.40 (95% CI, 0.22, 0.70) for PUMPrx. Neighborhood context, insurance, marital and employment status, and number of clinic visits were also associated with the outcomes. CONCLUSIONS: Significant racial disparities were observed in discussions, prescribing, and use of diabetes technology. Further research is needed to identify the causes behind these disparities and develop and evaluate strategies to reduce them.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Kanbour S, Jones M, Abusamaan MS, et al. Racial Disparities in Access and Use of Diabetes Technology Among Adult Patients With Type 1 Diabetes in a U.S. Academic Medical Center. Diabetes Care. 2023. PMID: 36378855. doi:10.2337/dc22-1055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。